{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:37Z","timestamp":1792032937417,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,7]],"date-time":"2027-04-07T00:00:00Z","timestamp":1807056000000},"content-version":"am","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dmpk.2026.101519","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:17:13Z","timestamp":1768407433000},"page":"101519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549\u00a0cells"],"prefix":"10.1016","volume":"68","author":[{"given":"Takuto","family":"Inamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9884-2768","authenticated-orcid":false,"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5988","authenticated-orcid":false,"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2026.101519_bib1","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1261\/rna.063503.117","article-title":"The RNA modification landscape in human disease","volume":"23","author":"Jonkhout","year":"2017","journal-title":"RNA"},{"key":"10.1016\/j.dmpk.2026.101519_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1101\/gad.262766.115","article-title":"RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation","volume":"29","author":"Yue","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.dmpk.2026.101519_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0092-8674(74)90153-6","article-title":"Existence of methylated messenger RNA in mouse L cells","volume":"1","author":"Perry","year":"1974","journal-title":"Cell"},{"key":"10.1016\/j.dmpk.2026.101519_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.dmpk.2026.101519_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates uuuuammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.dmpk.2026.101519_bib6","first-page":"1233","article-title":"Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase","volume":"3","author":"Bokar","year":"1997","journal-title":"RNA"},{"key":"10.1016\/j.dmpk.2026.101519_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.dmpk.2026.101519_bib8","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.dmpk.2026.101519_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.dmpk.2026.101519_bib10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1126\/science.1261417","article-title":"m6A mRNA methylation facilitates resolution of na\u00efve pluripotency toward differentiation","volume":"347","author":"Geula","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.dmpk.2026.101519_bib11","article-title":"The epitranscriptome and innate immunity","volume":"11","author":"O'Connell","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.dmpk.2026.101519_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","article-title":"RNA-methylation-dependent RNA processing controls the speed of the circadian clock","volume":"155","author":"Fustin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.dmpk.2026.101519_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","article-title":"The critical role of RNA m6A modification in cancer","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.dmpk.2026.101519_bib14","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","article-title":"American society of clinical oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer","volume":"27","author":"Azzoli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dmpk.2026.101519_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tcb.2019.02.008","article-title":"Regulation of gene expression by N6-methyladenosine in cancer progression","volume":"29","author":"Liu","year":"2019","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.dmpk.2026.101519_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m6A modification in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.dmpk.2026.101519_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2019.03.093","article-title":"The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA","volume":"512","author":"Li","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dmpk.2026.101519_bib18","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.dmpk.2026.101519_bib19","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.dmpk.2026.101519_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: an important regulator of tumor growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.dmpk.2026.101519_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2015.12.001","article-title":"Cancer stem cells in drug resistant lung cancer: targeting cell surface markers and signaling pathways","volume":"158","author":"Leon","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2026.101519_bib22","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.1016\/j.biomaterials.2011.08.041","article-title":"Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel-polymer micelles to overcome multi-drug resistance","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.dmpk.2026.101519_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104971","article-title":"YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549\/Taxol cells","volume":"69","author":"Gao","year":"2020","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.dmpk.2026.101519_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/1535-7163.MCT-07-2088","article-title":"MRP7\/ABCC10 expression is a predictive biomarker for the resistance to non-small cell lung cancer","volume":"7","author":"Oguri","year":"2008","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.dmpk.2026.101519_bib25","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.dmpk.2026.101519_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2009.08.021","article-title":"Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance","volume":"79","author":"Kuang","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmpk.2026.101519_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113697","article-title":"Methylation of adenosine at the N6 position post-transcriptionally regulates hepatic P450s expression","volume":"171","author":"Nakano","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmpk.2026.101519_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7116","article-title":"Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1","volume":"11","author":"Peng","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.dmpk.2026.101519_bib29","first-page":"1938","article-title":"MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis","volume":"9","author":"Tong","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.dmpk.2026.101519_bib30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/1759-7714.13409","article-title":"Validated LC-MS\/MS method of sphingosine 1-phosphate quantification in human serum for evaluation of response to radiotherapy in lung cancer","volume":"11","author":"Tang","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.dmpk.2026.101519_bib31","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/aps.2017.164","article-title":"A miRNA-200c\/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition","volume":"39","author":"Zhao","year":"2018","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.dmpk.2026.101519_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.dmpk.2026.101519_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.taap.2016.09.020","article-title":"Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters","volume":"310","author":"N\u011bmcov\u00e1-F\u00fcrstov\u00e1","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmpk.2026.101519_bib34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ng.465","article-title":"SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas","volume":"41","author":"Bass","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.dmpk.2026.101519_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114766","article-title":"m6A modification impacts drug and lipid metabolism properties by regulating carboxylesterase 2","volume":"193","author":"Takemoto","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmpk.2026.101519_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cmdc.201300428","article-title":"A cell-permeable ester derivative of the JmiC histone demethylase inhibitor IOX1","volume":"9","author":"Schiller","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.dmpk.2026.101519_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ijmm.2015.2393","article-title":"IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins","volume":"37","author":"Hu","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.dmpk.2026.101519_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1087057115623264","article-title":"A radioactivity-based assay for screening human m6A-RNA methyltransferase, METTL3-METTL14 complex, and demethylase ALKBH5","volume":"21","author":"Li","year":"2016","journal-title":"J Biomol Screen"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436726000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436726000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:14:28Z","timestamp":1778800468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436726000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S1347436726000054"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2026.101519","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549\u00a0cells","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2026.101519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101519"}}